These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19109035)

  • 21. Tumefactive demyelinating lesions during etanercept treatment requiring decompressive hemicraniectomy.
    Cereda CW; Zecca C; Mazzucchelli L; Valci L; Staedler C; Bassetti CL; Gobbi C
    Mult Scler; 2013 May; 19(6):820-3. PubMed ID: 23069873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-alpha blocking agents: two cases.
    Lourari S; Prey S; Livideanu C; Jamard B; Lamant L; Cantagrel A; Paul C
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):967-8. PubMed ID: 19192017
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-TNF antibodies: lessons from the past, roadmap for the future.
    Shealy DJ; Visvanathan S
    Handb Exp Pharmacol; 2008; (181):101-29. PubMed ID: 18071943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Missed opportunities in the treatment of elderly patients with rheumatoid arthritis.
    Radovits BJ; Fransen J; Eijsbouts A; van Riel PL; Laan RF
    Rheumatology (Oxford); 2009 Aug; 48(8):906-10. PubMed ID: 19478038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn's disease.
    Thomas CW; Weinshenker BG; Sandborn WJ
    Inflamm Bowel Dis; 2004 Jan; 10(1):28-31. PubMed ID: 15058523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
    Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
    J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-tumor necrosis factor nonresponders in Crohn's disease: therapeutic strategies.
    Louis E; Belaiche J; Reenaers C
    Dig Dis; 2009; 27(3):351-7. PubMed ID: 19786764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New-onset demyelination induced by infliximab therapy in two rheumatoid arthritis patients.
    Tanno M; Nakamura I; Kobayashi S; Kurihara K; Ito K
    Clin Rheumatol; 2006 Nov; 25(6):929-33. PubMed ID: 16328088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-tumor necrosis factor-alpha therapy provokes latent leishmaniasis in a patient with rheumatoid arthritis.
    Franklin G; Greenspan J; Chen S
    Ann Clin Lab Sci; 2009; 39(2):192-5. PubMed ID: 19429808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Technology evaluation: ISIS-104838, OraSense.
    Kennewell P
    Curr Opin Mol Ther; 2003 Feb; 5(1):76-80. PubMed ID: 12669475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crohn's disease: is there a place for neurological screening?
    Stovicek J; Liskova P; Lisy J; Hlava S; Keil R
    Scand J Gastroenterol; 2014 Feb; 49(2):173-6. PubMed ID: 24299027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Demyelinating neuropathy during anti-TNF alpha treatment with a review of the literature].
    Hamon MA; Nicolas G; Deviere F; Letournel F; Dubas F
    Rev Neurol (Paris); 2007 Dec; 163(12):1232-5. PubMed ID: 18355471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulsating back pain associated with tumor necrosis factor-alpha blockade.
    Rozin AP; Braun-Moscovici Y; Balbir-Gurman A
    Ann Pharmacother; 2008 Dec; 42(12):1912-3. PubMed ID: 19033477
    [No Abstract]   [Full Text] [Related]  

  • 34. Lewis-Sumner syndrome associated with infliximab therapy in rheumatoid arthritis.
    Hooper DR; Tarnopolsky MA; Baker SK
    Muscle Nerve; 2008 Oct; 38(4):1318-25. PubMed ID: 18671292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal relationship between antitumor necrosis factor-alpha antibody therapy and recrudescence of head and neck squamous cell carcinoma.
    Engel SH; Hullar TE; Adkins DR; Thorstad WL; Sunwoo JB
    Laryngoscope; 2008 Mar; 118(3):450-2. PubMed ID: 18090867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disseminated tuberculosis in a Crohn's disease patient on anti-TNF alpha therapy despite chemoprophylaxis.
    Bourikas LA; Kourbeti IS; Koutsopoulos AV; Koutroubakis IE
    Gut; 2008 Mar; 57(3):425; author reply 425-6. PubMed ID: 18268059
    [No Abstract]   [Full Text] [Related]  

  • 37. [Neutralisation of interferon gamma--a new trend in therapy of rheumatoid arthritis].
    Nasonova VA; Lukina GV; Sigidin IaA
    Ter Arkh; 2008; 80(5):30-7. PubMed ID: 18590111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies to tumor necrosis factor in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Rosenau BJ; Schur PH
    J Rheumatol; 2009 Apr; 36(4):753-6. PubMed ID: 19273453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-cytokine therapy in inflammatory joint diseases].
    Ehrenfeld M; Langevitz P; Shoenfeld Y
    Harefuah; 1999 Aug; 137(3-4):120-4. PubMed ID: 10959300
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
    de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M
    Digestion; 2008; 78(4):195-200. PubMed ID: 19122456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.